Preparing for the availability of a partially effective HIV vaccine: some lessons from other licensed vaccines

Vaccine. 2011 Aug 18;29(36):6072-8. doi: 10.1016/j.vaccine.2011.07.015. Epub 2011 Jul 13.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • AIDS Vaccines / economics
  • AIDS Vaccines / immunology
  • AIDS Vaccines / standards*
  • AIDS Vaccines / supply & distribution
  • Clinical Trials as Topic
  • Developing Countries
  • Genetic Variation
  • HIV Antigens / genetics
  • HIV Antigens / immunology
  • HIV Infections / immunology
  • HIV Infections / prevention & control*
  • HIV-1 / immunology
  • HIV-1 / pathogenicity
  • Hepatitis B Vaccines / economics
  • Hepatitis B Vaccines / immunology
  • Hepatitis B Vaccines / standards
  • Humans
  • Influenza Vaccines / immunology
  • Influenza Vaccines / standards
  • Licensure*
  • Papillomavirus Vaccines / economics
  • Papillomavirus Vaccines / immunology
  • Thailand
  • Vaccination

Substances

  • AIDS Vaccines
  • HIV Antigens
  • Hepatitis B Vaccines
  • Influenza Vaccines
  • Papillomavirus Vaccines